Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-17-017617

10% owner sold 15,000 shares at $16.00 ($240,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
TEPPER ROBERT I 10% owner 2017-06-29 Sale −15,000 $16.00 $240,000 44,777 D: show line 1 in the form
Open-market sales · 15,000 sh · avg $16.00 · $240,000
Loading xslF345X03/doc4.xml…